David S. Briones - 06 Jan 2022 Form 4 Insider Report for Larkspur Health Acquisition Corp. (ZVSA)

Reporting relationship: Chief Financial Officer, Director
Issuer ticker: ZVSA
Reported as of: 06 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Mar 2022, 16:30:21 UTC
Prior SEC filing: 20 Dec 2021
Next SEC filing: 15 May 2025
Source filing: View source filing
Reporting owner signature: /s/ David Briones

Key filing fact

David S. Briones filed Form 4 for Larkspur Health Acquisition Corp. (ZVSA) on 10 Mar 2022.

Key facts

This page summarizes David S. Briones's Form 4 filing for Larkspur Health Acquisition Corp. (ZVSA).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Mar 2022, 16:30.

Change

Previous filing in this sequence was filed on 20 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZVSA transaction

Class A Common Stock

Other

Transaction value: $0
Shares: +10,752
Change %
Price: $0.000000
Shares after: 10,752
Date: 06 Jan 2022
Ownership: see footnote
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZVSA transaction Derivative

Class B common stock

Other

Transaction value: $0
Shares: -1,533
Change %: -2.7%
Price: $0.000000
Shares after: 55,967
Date: 06 Jan 2022
Ownership: see footnote
Underlying class: Class A common stock
Underlying amount: 1,533
Exercise price
Footnotes: F2, F3, F4

ZVSA transaction Derivative

Class B common stock

Other

Transaction value: $0
Shares: +91
Change %: +0.16%
Price: $0.000000
Shares after: 56,123
Date: 06 Jan 2022
Ownership: see footnote
Underlying class: Class A common stock
Underlying amount: 156
Exercise price
Footnotes: F2, F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.

Footnote F2

The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Footnote F3

As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

Footnote F4

As contemplated in connection with the initial public offering of the Issuer, 22,343 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement.

Footnote F5

In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the Sponsor for no consideration.